79 y/o M with high-grade muscle-invasive urothelial carcinoma of the bladder trigone s/p TURBT c/w stage II (T2bN0M0) with no residual tumor on cystoscopy
He was treated with definitive chemoradiation using IMRT and concurrent 5-FU and mitomycin C (MMC) due to impaired renal function. He received 41.4Gy in 23 fractions to the whole bladder, prostate and low pelvic nodes followed by a boost of 19.8 Gy in 11 fractions to the partial bladder for total dose 61.2Gy in 34 fractions to the post-operative bed.
RT coverage and dose (per RTOG 0926 and NCCN 1.2016):
*Daily IGRT recommended when treating whole bladder without nodes and/or partial bladder boost (per NCCN 1.2016). Treating partial bladder NOT recommended for tumors of bladder dome (reproducibility).
General Management (per NCCN 1.2016):
Also available: ARROCase
Questions? Feedback? Report here